Age
Item
aged 30 and older
boolean
C0001779 (UMLS CUI [1])
Premenopausal state Follicle stimulating hormone measurement
Item
premenopausal (may be confirmed by fsh)
boolean
C0232969 (UMLS CUI [1,1])
C0202022 (UMLS CUI [1,2])
Malignant Neoplasms | Skin carcinoma
Item
no previous diagnosis of cancer (except non-melanomatous skin cancer)
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
Body mass index
Item
body mass index between 25-34 kg/m2
boolean
C1305855 (UMLS CUI [1])
Gender Reside Geographic area
Item
women must be expected to live in the columbus area for the next 18 months.
boolean
C0079399 (UMLS CUI [1,1])
C2982691 (UMLS CUI [1,2])
C0017446 (UMLS CUI [1,3])
Gender Letter Medical Clearance
Item
all women must present a letter of medical clearance from their primary care physician.
boolean
C0079399 (UMLS CUI [1,1])
C0746461 (UMLS CUI [1,2])
C4042833 (UMLS CUI [1,3])
Pregnancy | Pregnancy, Planned
Item
pregnant women or women who plan to become pregnant during the study period will not be enrolled. women who become pregnant during the intervention will be withdrawn from the study.
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Gender Participation Weight Reduction Program
Item
women who are already participating in a formal weight loss program (such as weight watchers)will not be eligible.
boolean
C0079399 (UMLS CUI [1,1])
C0679823 (UMLS CUI [1,2])
C3179079 (UMLS CUI [1,3])
Gender | Medical History Excludes Dietary Patterns Quantity | Renal Insufficiency | Gluten enteropathy | Crohn Disease | Medical condition Impact Nutritional status | Medical condition Impact Metabolism | Diabetes Mellitus, Insulin-Dependent | Non-Insulin-Dependent Diabetes Mellitus Controlled
Item
women with a medical history that precludes adherence to either of the two dietary patterns will also be excluded. this includes a history of renal insufficiency, gluten enteropathy, crohn's disease or other medical conditions that significantly impact nutritional status or metabolism. women with either type i or controlled type ii diabetes will be eligible to participate in this trial.
boolean
C0079399 (UMLS CUI [1])
C0262926 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C1517289 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C1565489 (UMLS CUI [3])
C0007570 (UMLS CUI [4])
C0010346 (UMLS CUI [5])
C3843040 (UMLS CUI [6,1])
C4049986 (UMLS CUI [6,2])
C0392209 (UMLS CUI [6,3])
C3843040 (UMLS CUI [7,1])
C4049986 (UMLS CUI [7,2])
C0025519 (UMLS CUI [7,3])
C0011854 (UMLS CUI [8])
C0011860 (UMLS CUI [9,1])
C2911690 (UMLS CUI [9,2])
Problem Medical Controlled | Lipids profile test | Blood Glucose Assessment | Glycosylated hemoglobin A Assessment | Blood Pressure Assessment
Item
all medical problems must be managed and controlled. lipid profile, blood glucose, hemoglobin a1c, and blood pressure will be assessed at the screening visit. these results will be reviewed by the study physician. women who have abnormal values that, at the discretion of the study physician, would benefit from medical management will be referred to a primary care physician prior to considering them for enrollment.
boolean
C0033213 (UMLS CUI [1,1])
C0205476 (UMLS CUI [1,2])
C2587213 (UMLS CUI [1,3])
C0850354 (UMLS CUI [2])
C0005802 (UMLS CUI [3,1])
C1516048 (UMLS CUI [3,2])
C0019018 (UMLS CUI [4,1])
C1516048 (UMLS CUI [4,2])
C0005823 (UMLS CUI [5,1])
C1516048 (UMLS CUI [5,2])